PR NewswireIRVINE, Calif., March 12, 2025
IRVINE, Calif., March 12, 2025 /PRNewswire/ -- Newmark Group, Inc. (Nasdaq: NMRK) ("Newmark" or "the Company"), a
BEDMINSTER, N.J., March 11, 2025 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. ( American: MTNB) today announced the appointment of biotech industry ve
BOSTON & MONTREAL — enGene Holdings Inc. (Nasdaq: ENGN or “enGene” or the “Company”), a clinical-stage genetic medicines company whose non-viral lead investigation…
Oruka is advancing a pipeline of potentially best-in-class biologics that aim to offer greater freedom from disease to people with plaque psoriasis and...
Century is pursuing additional autoimmune disease regulatory filings for its iPSC derived iNK cell therapy, CNTY-101, beyond CALiPSO-1 trial in SLE, based...
Jim Creamer Appointed as Interim Chief Financial Officer Clifford Neuman Appointed to Board of Directors Greenwood Village, CO, Dec. 19, 2023 (GLOBE...
- Treated the first patient with advanced inoperable pancreatic cancer at Hadassah Medical Center in Israel in September, alongside safety and feasibility...
Mr. Creamer, the Company’s Chief Financial Officer, brings additional public company experience to the company’s Board of Directors. Denver, Colorado,...
Mr. Creamer returns to his former role as the Company’s CFO as the Company continues its push to bring additional experienced management in anticipation of...